Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

12. CALL/PUT OPTION (Details)

v3.21.2
12. CALL/PUT OPTION (Details) - CAD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Financing expense (income) $ 0 $ (2,340,164)
Interest not received in cash (4,099,526) (3,832,577)
Transferred to Call/Put Options   23,955,576
Fair value of OpCo Debenture   36,419,594
Revaluation increase (decrease), intangible assets other than goodwill [1] 53,619,465 (4,407,819)
Call/put option [1] $ 112,658,740 55,967,351
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Method Used Monte Carlo simulation valuation model  
Convertible Debenture #1    
Gain (Loss) on Foreign Currency Translation   $ (1,027,602)
Call option    
Reclassification, Amount $ 19,547,757  
Call/Put Option #1    
Sale of Stock, Transaction Date   Jan. 04, 2019
Sale of Stock, Description of Transaction   MichiCann entered into a call/put option agreement (the “Call/Put Option Agreement”) with PharmaCo Inc.
Call/Put Option #2    
Sale of Stock, Transaction Date   Jan. 04, 2019
Sale of Stock, Description of Transaction   MichiCann entered a Debenture Purchase Agreement with PharmaCo
[1] Note 12.